Open AccessIleocolic Anastomotic Site Recurrence
Author(s) -
Alojaym Tariq,
Faisal Siddiqi,
Naila Zahid,
Hira Khan
Publication year - 2022
Publication title -
liaquat national journal of cancer care
Language(s) - English
Resource type - Journals
eISSN - 2789-0120
pISSN - 2789-0112
DOI - 10.37184/lnjcc.2789-0112.3.4
Subject(s) - medicine , anastomosis , colorectal cancer , palliative chemotherapy , surgery , chemotherapy , adenocarcinoma , palliative treatment , medical treatment , general surgery , metastasis , distant metastasis , cancer , intensive care medicine
Colorectal cancer is associated with high mortality. 50% of the patients tend to develop recurrence even after curative treatment. Most of the recurrences are found in the first three years and a few in five years. Early detection of recurrence is important to improve a patient’s survival. Many follow-up plans have been devised for surveillance. Very scant evidence is available in the literature for palliative treatment by chemotherapy of recurrent bowel adenocarcinoma. In advanced cases of recurrence at Ileocolic anastomosis in which medical treatment has failed ileocolic resection is indicated. There is 70% anastomotic recurrence after ileocolic resection.We are reporting a case of a 47-year-old Asian female who had recurrent colorectal anastomotic site adenocarcinoma and developed peritoneal metastasis. She underwent palliative surgery followed by chemotherapy and will be under observation.